Yahoo

Wegovy, Zepbound and the weight-loss drugs reshaping Americans

Amber DeBirk tipped the scales at 206 pounds last November and she worried a lot about being around to see her daughters, now 18 and 20, settle well into adulthood. She was turning 50 and wanted time ...
Seeking Alpha

Zepbound (tirzepatide) showed superior weight loss over Wegovy (semaglutide) in complete SURMOUNT-5 results published in The New England Journal of Medicine

Participants achieved an average weight loss of 20.2% with Zepbound vs. 13.7% with Wegovy In key secondary endpoints, Zepbound was superior to Wegovy across all weight reduction targets and ...
Healthline

Why Am I Not Losing Weight on Zepbound?

Zepbound (tirzepatide) is a brand-name injection prescribed for weight loss, weight management, and more. You may need to take Zepbound for several months to see the full effects of the drug ...
The Economist

The plan to rescue Denmark’s weight-loss pioneer

For more than two years it had the entirety of the market for weight-loss drugs to itself. By 2023 sales of Wegovy had ...
Us Weekly

Claudia Oshry Shares She’s Taking Weight Loss Drugs Again After Giving Birth: ‘War Is Over’

Claudia Oshry got real about her postpartum body. Oshry, 31, took to Instagram on Monday, December 15, to share that she’s ...

Target beefs up protein, supplement offerings, capitalizing on weight loss drug trend

Target has expanded its protein and supplement sections as GLP-1 drugs like Ozempic reshape shopping habits, driving demand ...
Everyday Health on MSN

New Obesity Drug Helped People Lose Nearly One-Third Their Body Weight

The clinical trial showed this experimental medication to be much more effective than any existing GLP-1 drug. But that much ...

Lilly’s experimental shot reduces body weight by 23% in study

A next-generation obesity shot from Eli Lilly & Co. helped patients lose almost a quarter of their body weight, potentially making the experimental drug the most potent weight loss medicine yet.